Parekh Parth J, Shams Rouzbeh, Oldfield E C, Nicholas Julian J, Johnson David A
*Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tulane University, New Orleans, LA †Department of Internal Medicine, Eastern Virginia Medical School, Norfolk, VA ‡Eastern Virginia Medical School, Norfolk, VA §Department of Gastroenterology, Scripps Health, San Diego, CA ∥Department of Internal Medicine, Gastroenterology Division, Eastern Virginia Medical School, Norfolk, VA.
J Clin Gastroenterol. 2014 Oct;48(9):745-51. doi: 10.1097/MCG.0000000000000188.
In 2008, results from the landmark American College of Radiology Imaging Network (ACRIN) trial provided evidence supporting the use computed tomography colonography (CTC) as a comparable alternative to colonoscopy for colorectal cancer (CRC) screening. Subsequently, however, the United States Preventive Task Force decided against a recommendation in support of CTC for CRC screening. Following soon after, the Centers for Medicare and Medicaid Services (CMS) made noncoverage decision for the use of CTC in CRC screening. Since that decision, there have been a number of publications on CTC and CRC screening with a strong push from the radiology community to reassess CTC as a viable option. The purpose of this review was to address focused questions concerning the use of CTC in CRC screening, through an analysis of the available scientific evidence in an effort to provide recommendations for clinicians, patients, and payors who may evaluate the role of CTC for CRC screening.
2008年,具有里程碑意义的美国放射学会影像网络(ACRIN)试验结果提供了证据,支持将计算机断层扫描结肠成像(CTC)作为结肠镜检查用于结直肠癌(CRC)筛查的可比替代方法。然而,随后美国预防服务工作组决定不支持推荐使用CTC进行CRC筛查。紧接着,医疗保险和医疗补助服务中心(CMS)做出了不覆盖使用CTC进行CRC筛查的决定。自该决定以来,有许多关于CTC和CRC筛查的出版物,放射学界强烈推动重新评估CTC作为一种可行选择。本综述的目的是通过分析现有科学证据,解决有关在CRC筛查中使用CTC的重点问题,以便为可能评估CTC在CRC筛查中作用的临床医生、患者和支付方提供建议。